| 1 |
钱桂生. 急性肺损伤和急性呼吸窘迫综合征研究现状与展望[J]. 解放军医学杂志，2003, 28(2): 97-101.
|
| 2 |
熊欢庆，李玉娟，陈 键，等. 丹参酮ⅡA及苦参碱组方对脂多糖致小鼠急性肺损伤的协同保护作用[J/CD].中华肺部疾病杂志(电子版), 2023, 16(4): 455-459.
|
| 3 |
Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury[J]. N Engl J Med, 2005, 353(16): 1685-1693.
|
| 4 |
Jang SI, Jeong SI, Kim KJ, et al. Tanshinone ⅡA from Salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-alpha, IL-1beta and IL-6 in activated RAW 264.7 cells[J]. Planta Med, 2003, 69(11): 1057-1059.
|
| 5 |
Shi Y, Zhang B, Chen XJ, et al. Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2[J]. Eur J Pharm Sci, 2013, 48(4-5): 819-824.
|
| 6 |
Xie XY, Zhang B, Li JH, et al. Sodium tanshinone iia sulfonate attenuates seawater aspiration-induced acute pulmonary edema by up-regulating Na(＋)，K(＋)-ATPase activity[J]. Exp Lung Res, 2011, 37(8): 482-491.
|
| 7 |
Li J, Xu M, Fan Q, et al. Tanshinone ⅡA ameliorates seawater exposure-induced lung injury by inhibiting aquaporins (AQP) 1 and AQP5 expression in lung[J]. Respir Physiol Neurobiol, 2011, 176(1-2): 39-49.
|
| 8 |
Ware LB, Matthay MA. The acute respiratory distress syndrome[J]. N Engl J Med, 2000, 342(18): 1334-1349.
|
| 9 |
Baetz D, Shaw J, Kirshenbaum LA. Nuclear factor-kappaB decoys suppress endotoxin-induced lung injury[J]. Mol Pharmacol, 2005, 67(4): 977-979.
|
| 10 |
Raetz CR, Whitfield C. Lipopolysaccharide endotoxins[J]. Annu Rev Biochem, 2002, 71: 635-700.
|
| 11 |
Conti G, Tambalo S, Villetti G, et al. Evaluation of lung inflammation induced by intratracheal administration of LPS in mice: comparison between MRI and histology[J]. MAGMA, 2010, 23(2): 93-101.
|
| 12 |
Stangherlin A, Reddy AB. Regulation of circadian clocks by redox homeostasis[J]. J Biol Chem, 2013, 288(37): 26505-26511.
|
| 13 |
Bernard GR, Artigas A, Brigham KL, et al. The american-european consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination[J]. Am J Respir Crit Care Med, 1994, 149(3 Pt 1): 818-824.
|
| 14 |
Russo TA, Bartholomew LA, Davidson BA, et al. Total extracellular surfactant is increased but abnormal in a rat model of gram-negative bacterial pneumonia[J]. Am J Physiol Lung Cell Mol Physiol, 2002, 283(3): L655-L663.
|
| 15 |
Takano H, Inoue K, Yanagisawa R, et al. Protective role of metallothionein in acute lung injury induced by bacterial endotoxin[J]. Thorax, 2004, 59(12): 1057-1062.
|
| 16 |
杜冠华，张均田. 丹参现代研究概况与进展(续一)[J]. 医药导报，2004, 23(6): 355-360.
|
| 17 |
胡咏武，王胜春，李 哲. 丹参酮ⅡA对LPS等诱导的肝细胞损伤及枯否细胞释放细胞因子的作用[J]. 中国药理学通报，2005, 21(12): 1482-1486.
|
| 18 |
Choi HS, Cho DI, Choi HK, et al. Molecular mechanisms of inhibitory activities of tanshinones on lipopolysaccharide-induced nitric oxide generation in RAW 264.7 cells[J]. Arch Pharm Res, 2004, 27(12): 1233-1237.
|
| 19 |
Jang SI, Kim HJ, Kim YJ, et al. Tanshinone ⅡA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways[J]. Eur J Pharmacol, 2006, 542(1-3): 1-7.
|
| 20 |
Chen TH, Hsu YT, Chen CH, et al. Tanshinone ⅡA from Salvia miltiorrhiza induces heme oxygenase-1 expression and inhibits lipopolysaccharide-induced nitric oxide expression in RAW 264.7 cells[J]. Mitochondrion, 2007, 7(1-2): 101-105.
|
| 21 |
Xu M, Dong MQ, Cao FL, et al. Tanshinone ⅡA reduces lethality and acute lung injury in LPS-treated mice by inhibition of PLA2 activity[J]. Eur J Pharmacol, 2009, 607(1-3): 194-200.
|
| 22 |
卢志坤，陈一平. 酚妥拉明联合丹参酮治疗糖尿病周围神经病变临床观察[J]. 浙江临床医学，2007, 9(4): 472.
|
| 23 |
潘晓群，庄宇亮. 丹参酮ⅡA磺酸钠注射液治疗老年冠心病30例[J]. 中国临床保健杂志，2006, 9(1): 74-75.
|
| 24 |
Won SH, Lee HJ, Jeong SJ, et al. Tanshinone ⅡA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway[J]. Biol Pharm Bull, 2010, 33(11): 1828-1834.
|
| 25 |
Alam SSM, Samanta A, Uddin F, et al. Tanshinone ⅡA targeting cell signaling pathways: a plausible paradigm for cancer therapy[J]. Pharmacol Rep, 2023, 75(4): 907-922.
|
| 26 |
Xu M, Cao FL, Zhang YF, et al. Tanshinone ⅡA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice[J]. Acta Pharmacol Sin, 2015, 36(2): 179-187.
|
| 27 |
Shi XM, Huang L, Xiong SD, et al. Protective effect of tanshinone ⅡA on lipopolysaccharide-induced lung injury in rats[J]. Chin J Integr Med, 2007, 13(2): 137-140.
|
| 28 |
Hoult JR, Paya M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential[J]. Gen Pharmacol，1996, 27(4): 713-722.
|
| 29 |
Chou SY, Hsu CS, Wang KT, et al. Antitumor effects of Osthol from Cnidium monnieri: an in vitro and in vivo study[J]. Phytother Res, 2007, 21(3): 226-230.
|
| 30 |
Xu X, Zhang Y, Qu D, et al. Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells by modulating PI3K/Akt pathway[J]. J Exp Clin Cancer Res, 2011, 30(1): 33.
|
| 31 |
Okamoto T, Kawasaki T, Hino O. Osthole prevents anti-Fas antibody-induced hepatitis in mice by affecting the caspase-3-mediated apoptotic pathway[J]. Biochem Pharmacol, 2003, 65(4): 677-681.
|
| 32 |
Zhang Q, Qin L, He W, et al. Coumarins from Cnidium monnieri and their antiosteoporotic activity[J]. Planta Med, 2007, 73(1): 13-19.
|
| 33 |
Matsuda H, Tomohiro N, Ido Y, et al. Anti-allergic effects of cnidii monnieri fructus (dried fruits of Cnidium monnieri) and its major component, osthol[J]. Biol Pharm Bull, 2002, 25(6): 809-812.
|
| 34 |
He Y, Qu S, Wang J, et al. Neuroprotective effects of osthole pretreatment against traumatic brain injury in rats[J]. Brain Res, 2012, 1433: 127-136.
|
| 35 |
Nakamura T, Kodama N, Arai Y, et al. Inhibitory effect of oxycoumarins isolated from the Thai medicinal plant Clausena guillauminii on the inflammation mediators, iNOS, TNF-alpha, and COX-2 expression in mouse macrophage RAW 264.7[J]. J Nat Med, 2009, 63(1): 21-27.
|
| 36 |
Chen XJ, Zhang B, Hou SJ, et al. Osthole improves acute lung injury in mice by up-regulating Nrf-2/thioredoxin 1[J]. Respir Physiol Neurobiol, 2013, 188(2): 214-222.
|
| 37 |
Kuo PL, Hsu YL, Chang CH, et al. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells[J]. J Pharmacol Exp Ther, 2005, 314(3): 1290-1299.
|
| 38 |
Shi Y, Zhang B, Chen XJ, et al. Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2[J]. Eur J Pharm Sci, 2013, 48(4-5): 819-824.
|
| 39 |
Li F, Gong Q, Wang L, et al. Osthole attenuates focal inflammatory reaction following permanent middle cerebral artery occlusion in rats[J]. Biol Pharm Bull, 2012, 35(10): 1686-1690.
|
| 40 |
Liao PC, Chien SC, Ho CL, et al. Osthole regulates inflammatory mediator expression through modulating NF-kappaB, mitogen-activated protein kinases, protein kinase C, and reactive oxygen species[J]. J Agric Food Chem, 2010, 58(19): 10445-10451.
|